Boston Scientific Corporation (BSX)
NYSE: BSX · Real-Time Price · USD
92.02
-1.77 (-1.89%)
Jan 29, 2026, 2:03 PM EST - Market open
Boston Scientific Employees
Boston Scientific had 53,000 employees as of December 31, 2024. The number of employees increased by 5,000 or 10.42% compared to the previous year.
Employees
53,000
Change (1Y)
5,000
Growth (1Y)
10.42%
Revenue / Employee
$365,075
Profits / Employee
$52,660
Market Cap
136.47B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 53,000 | 5,000 | 10.42% |
| Dec 31, 2023 | 48,000 | 3,000 | 6.67% |
| Dec 31, 2022 | 45,000 | 4,000 | 9.76% |
| Dec 31, 2021 | 41,000 | 3,000 | 7.89% |
| Dec 31, 2020 | 38,000 | 2,000 | 5.56% |
| Dec 31, 2019 | 36,000 | 4,000 | 12.50% |
| Dec 31, 2018 | 32,000 | 3,000 | 10.34% |
| Dec 31, 2017 | 29,000 | 2,000 | 7.41% |
| Dec 31, 2016 | 27,000 | 2,000 | 8.00% |
| Dec 31, 2015 | 25,000 | 1,000 | 4.17% |
| Dec 31, 2014 | 24,000 | 1,000 | 4.35% |
| Dec 31, 2013 | 23,000 | -1,000 | -4.17% |
| Dec 31, 2012 | 24,000 | 0 | - |
| Dec 31, 2011 | 24,000 | -1,000 | -4.00% |
| Dec 31, 2010 | 25,000 | -1,000 | -3.85% |
| Dec 31, 2009 | 26,000 | 1,200 | 4.84% |
| Dec 31, 2008 | 24,800 | -2,700 | -9.82% |
| Dec 31, 2007 | 27,500 | -1,100 | -3.85% |
| Dec 31, 2006 | 28,600 | 8,800 | 44.44% |
| Dec 31, 2005 | 19,800 | 2,300 | 13.14% |
| Dec 31, 2004 | 17,500 | 2,500 | 16.67% |
| Dec 31, 2003 | 15,000 | 1,100 | 7.91% |
| Dec 31, 2002 | 13,900 | -500 | -3.47% |
| Dec 31, 2001 | 14,400 | 680 | 4.96% |
| Dec 31, 2000 | 13,720 | 1,105 | 8.76% |
| Dec 31, 1999 | 12,615 | -1,385 | -9.89% |
| Dec 31, 1998 | 14,000 | 3,000 | 27.27% |
| Dec 31, 1997 | 11,000 | 1,420 | 14.82% |
| Dec 31, 1996 | 9,580 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| Abbott Laboratories | 114,000 |
| Medtronic | 95,000 |
| Koninklijke Philips | 67,823 |
| Stryker | 53,000 |
| GE HealthCare Technologies | 53,000 |
| Smith & Nephew | 18,060 |
| STERIS | 17,787 |
| Zimmer Biomet Holdings | 17,000 |
BSX News
- 4 hours ago - Artisan Global Opportunities Fund Q4 2025 Portfolio Update - Seeking Alpha
- 7 days ago - Polen Global Growth Portfolio Q4 2025 Performance, Attribution & Portfolio Activity - Seeking Alpha
- 8 days ago - BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: RAPT Therapeutics, Inc. (Nasdaq – RAPT), Penumbra, Inc. (NYSE – PEN), Calavo Growers, Inc. (Nasdaq – CVGW), FONAR Corporation (Nasdaq - FONR) - GlobeNewsWire
- 13 days ago - How Low Can Boston Scientific Stock Go When Markets Turn Sour? - Forbes
- 14 days ago - Boston Scientific Corporation (BSX) M&A Call Transcript - Seeking Alpha
- 14 days ago - BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Penumbra, Inc. (NYSE – PEN), Calavo Growers, Inc. (Nasdaq – CVGW), Clearwater Analytics Holdings, Inc. (NYSE - CWAN) - GlobeNewsWire
- 14 days ago - Boston Scientific to buy Penumbra in $14.5B deal to expand cardiovascular reach - Invezz
- 14 days ago - Penumbra Stock Jumps. It's Being Bought by Boston Scientific for $14.5 Billion. - Barrons